171 related articles for article (PubMed ID: 23563176)
41. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling.
Kubo T; Yamashita T; Yamaguchi A; Sumimoto H; Hosokawa K; Tohyama M
J Neurosci; 2002 Oct; 22(19):8504-13. PubMed ID: 12351724
[TBL] [Abstract][Full Text] [Related]
42. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
43. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
44. An Experimenter's Guide to Glioblastoma Invasion Pathways.
de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
[TBL] [Abstract][Full Text] [Related]
45. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
46. Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function.
Gimond C; van Der Flier A; van Delft S; Brakebusch C; Kuikman I; Collard JG; Fässler R; Sonnenberg A
J Cell Biol; 1999 Dec; 147(6):1325-40. PubMed ID: 10601344
[TBL] [Abstract][Full Text] [Related]
47. Oncogenic Dbl, Cdc42, and p21-activated kinase form a ternary signaling intermediate through the minimum interactive domains.
Wang L; Zhu K; Zheng Y
Biochemistry; 2004 Nov; 43(46):14584-93. PubMed ID: 15544329
[TBL] [Abstract][Full Text] [Related]
48. Roles of sphingosine-1-phosphate (S1P) receptors in malignant behavior of glioma cells. Differential effects of S1P2 on cell migration and invasiveness.
Young N; Van Brocklyn JR
Exp Cell Res; 2007 May; 313(8):1615-27. PubMed ID: 17376432
[TBL] [Abstract][Full Text] [Related]
49. RHGF-2 is an essential Rho-1 specific RhoGEF that binds to the multi-PDZ domain scaffold protein MPZ-1 in Caenorhabditis elegans.
Lin L; Tran T; Hu S; Cramer T; Komuniecki R; Steven RM
PLoS One; 2012; 7(2):e31499. PubMed ID: 22363657
[TBL] [Abstract][Full Text] [Related]
50. Decreased pygopus 2 expression suppresses glioblastoma U251 cell growth.
Wang ZX; Chen YY; Li BA; Tan GW; Liu XY; Shen SH; Zhu HW; Wang HD
J Neurooncol; 2010 Oct; 100(1):31-41. PubMed ID: 20204459
[TBL] [Abstract][Full Text] [Related]
51. Notch1 promotes glioma cell migration and invasion by stimulating β-catenin and NF-κB signaling via AKT activation.
Zhang X; Chen T; Zhang J; Mao Q; Li S; Xiong W; Qiu Y; Xie Q; Ge J
Cancer Sci; 2012 Feb; 103(2):181-90. PubMed ID: 22093097
[TBL] [Abstract][Full Text] [Related]
52. Functions of Rhotekin, an Effector of Rho GTPase, and Its Binding Partners in Mammals.
Ito H; Morishita R; Nagata KI
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037057
[TBL] [Abstract][Full Text] [Related]
53. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
[TBL] [Abstract][Full Text] [Related]
54. Rho regulation: DLC proteins in space and time.
Braun AC; Olayioye MA
Cell Signal; 2015 Aug; 27(8):1643-51. PubMed ID: 25889896
[TBL] [Abstract][Full Text] [Related]
55. Characterization of the expression of PDZ-RhoGEF, LARG and G(alpha)12/G(alpha)13 proteins in the murine nervous system.
Kuner R; Swiercz JM; Zywietz A; Tappe A; Offermanns S
Eur J Neurosci; 2002 Dec; 16(12):2333-41. PubMed ID: 12492428
[TBL] [Abstract][Full Text] [Related]
56. Rho GTPases: promising cellular targets for novel anticancer drugs.
Fritz G; Kaina B
Curr Cancer Drug Targets; 2006 Feb; 6(1):1-14. PubMed ID: 16475973
[TBL] [Abstract][Full Text] [Related]
57. ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma.
Chen J; Xia H; Zhang X; Karthik S; Pratap SV; Ooi LL; Hong W; Hui KM
J Hepatol; 2015 Jun; 62(6):1287-95. PubMed ID: 25617497
[TBL] [Abstract][Full Text] [Related]
58. Physical and functional interactions of the lysophosphatidic acid receptors with PDZ domain-containing Rho guanine nucleotide exchange factors (RhoGEFs).
Yamada T; Ohoka Y; Kogo M; Inagaki S
J Biol Chem; 2005 May; 280(19):19358-63. PubMed ID: 15755723
[TBL] [Abstract][Full Text] [Related]
59. ARHGEF7 (
Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
[TBL] [Abstract][Full Text] [Related]
60. Guanine nucleotide exchange factors for Rho GTPases (RhoGEFs) as oncogenic effectors and strategic therapeutic targets in metastatic cancer.
Cervantes-Villagrana RD; García-Jiménez I; Vázquez-Prado J
Cell Signal; 2023 Sep; 109():110749. PubMed ID: 37290677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
